Literature DB >> 17845246

Insulin-like growth factor I in growing thoroughbreds.

W B Staniar1, D S Kronfeld, R M Akers, P A Harris.   

Abstract

The objective of this longitudinal study was to characterize growth and plasma insulin-like growth factor I (IGF-I) concentrations in pasture-raised thoroughbreds fed two sources of dietary energy. Mares and foals were randomly assigned to either a sugar and starch (SS) or fat and fibre (FF)-rich feed, and plasma IGF-I and growth were measured once a month from 1 to 16 months of age. These dependent variables were also compared with day length and ambient temperature. There was an association between plasma IGF-I concentration and average daily gain (ADG) (r = 0.32, p < 0.001). There were also clear seasonal patterns in both ADG and plasma IGF-I, with high values in June and May, and a low value in March. Plasma IGF-I and ADG were positively associated with day length and temperature. Plasma IGF-I was never higher (p > 0.10) in the FF group when compared with the SS group, and was higher in the SS group during a rapid growth phase in the spring of year 2 (p < 0.10). The results establish an association between ADG and IGF-I in the horse and indicate that environment and age may influence this relationship. In addition, plasma IGF-I is influenced by dietary energy source at particular times of year. This link has important implications in designing feeding management strategies that are aimed at addressing skeletal development.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17845246     DOI: 10.1111/j.1439-0396.2006.00666.x

Source DB:  PubMed          Journal:  J Anim Physiol Anim Nutr (Berl)        ISSN: 0931-2439            Impact factor:   2.130


  1 in total

1.  Variations of plasmatic concentrations of Insulin-like Growth Factor-I in post-pubescent horses affected with developmental osteochondral lesions.

Authors:  D R Verwilghen; L Vanderheyden; T Franck; V Busoni; E Enzerink; M Gangl; J-P Lejeune; G van Galen; S Grulke; D Serteyn
Journal:  Vet Res Commun       Date:  2009-03-25       Impact factor: 2.459

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.